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A growing body of scientific literature suggests that not only changes in skeletal muscle
mass, but also other factors underpinning muscle quality, play a role in the decline in
skeletal muscle function and impaired mobility associated with aging. A symposium
on muscle quality and the need for standardized assessment was held on April 28,
2016 at the International Conference on Frailty and Sarcopenia Research in Philadelphia,
Pennsylvania. The purpose of this symposium was to provide a venue for basic science
and clinical researchers and expert clinicians to discuss muscle quality in the context of
skeletal muscle function deficit and other aging-related muscle dysfunctions. The present
article provides an expanded introduction concerning the emerging definitions of muscle
quality and a potential framework for scientific inquiry within the field. Changes in muscle
tissue composition, based on excessive levels of inter- and intra-muscular adipose
tissue and intramyocellular lipids, have been found to adversely impact metabolism and
peak force generation. However, methods to easily and rapidly assess muscle tissue
composition in multiple clinical settings and with minimal patient burden are needed.
Diagnostic ultrasound and other assessment methods continue to be developed for
characterizing muscle pathology, and enhanced sonography using sensors to provide
user feedback and improve reliability is currently the subject of ongoing investigation and
development. In addition, measures of relative muscle force such as specific force or
grip strength adjusted for body size have been proposed as methods to assess changes
in muscle quality. Furthermore, performance-based assessments of muscle power via
timed tests of function and body size estimates, are associated with lower extremity
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muscle strength may be responsive to age-related changes in muscle quality. Future
aims include reaching consensus on the definition and standardized assessments of
muscle quality, and providing recommendations to address critical clinical and technology
research gaps within the field.
Keywords: muscle quality, sarcopenia, muscle strength, muscle power, skeletal muscle function deficit,
myosteatosis, imaging
INTRODUCTION
A symposium was convened at the 2016 International
Conference on Frailty and Sarcopenia Research (April 28,
2016 in, Philadelphia, PA) to discuss the impact of muscle
quality on age-related muscle dysfunction and to explore
approaches to standardized assessment. Adverse changes in
muscle tissue composition have long been acknowledged as a
contributor to the diminished muscle performance observed
in older adults (Goodpaster et al., 2000; Manini et al., 2007).
However, the routine assessment of this muscle characteristic
has been limited due to a combination of factors. These factors
may include relatively high costs, access limitations in some
practice environments, and the testing burden associated with
invasive techniques. Importantly, the wider adoption of routine
tissue composition analysis is constrained by the need for
additional evidence to demonstrate its value in the diagnosis
of age-related muscle dysfunction, and utility in supporting
diagnostic and therapeutic decisions. Growing evidence does
suggest that age-related increases in intramuscular adipose
tissue may compromise muscle performance and metabolic
status (Miljkovic and Zmuda, 2010). Efforts to integrate these
clinically relevant research insights into practice have driven
the development of alternative assessment methods. Clinically
viable modalities ranging from multi-frequency electrical
impedance analysis to quantitative diagnostic sonography have
been recently developed to characterize skeletal muscle mass
and quality in older adults and those with muscle disease
(Harris-Love et al., 2014). There has also been increasing
interest in non-invasive, high precision, imaging modalities.
For example, magnetic resonance imaging (MRI) has been used
for the diagnosis and assessment of disease progression for a
number of neuromuscular diseases such as Duchenne muscular
dystrophy (Finanger et al., 2012). In addition, investigators have
increasingly integrated the concepts of peak force production
and body size to assess muscle performance and provide an
estimate of muscle quality (Cawthon et al., 2009; Fragala et al.,
2015b). Consequently, the selected symposium topics included a
brief review of potential mechanisms that adversely affect muscle
quality, and developing imaging methods and performance-
based tests used to assess muscle quality within a variety
of settings. The symposium presentations, and subsequent
panel discussion, highlighted the need for continued dialogue
concerning the definition and taxonomy used to describe muscle
quality. Therefore, the primary aims of this symposium report
are to introduce a potential framework for the study of muscle
quality, convey the metabolic and functional consequences of
poor muscle tissue composition, review a functional approach
to assessment that incorporates relative strength, and examine
emerging sonographic methods used to characterize muscle
tissue.
DEVELOPING A FRAMEWORK FOR
ASSESSING MUSCLE QUALITY
The age-related decline of skeletal muscle mass and its function
is associated with physical limitations, fall risk, disability, and
mortality in adults over the age of 60 (Janssen et al., 2002; Landi
et al., 2013; Charlier et al., 2015; Clynes et al., 2015; Brown
et al., 2016). These mobility impairments are often a precursor
of functional decline, disability, and loss of independence.
Consequently, sarcopenia continues to pose challenges to older
adults, their caregivers, and the U.S. healthcare system (Janssen
et al., 2004b). The decrease in lean body mass (LBM) associated
with sarcopenia often results in diminished muscle strength
or power (Morley, 2012). Peak muscle force as a function of
muscle size is a well-established precept in physiology (Bamman
et al., 2000). The observations by James Keill in the early 1700s
established that muscle strength corresponds to the number of
associated muscle fibers (Keill, 1708), and Ernst Weber (Narici
et al., 2016) investigated the relationship between maximum
isometric force and muscle cross-sectional area (CSA) in 1846.
Importantly, adverse changes in muscle quality, based on tissue
composition or peak force production, may precede a loss of
muscle mass. Evidence now shows that not only changes in
skeletal muscle mass, but other factors underpinning muscle
quality may play a role in the decline in skeletal muscle function
and impaired mobility associated with aging (Visser et al., 2005;
Goodpaster et al., 2006; Ferrucci et al., 2011). While muscle
size appears to contribute to losses in strength and physical
functioning, both the response to strength training and the
consequences of chronic disuse involve physiologic adaptations
that are intrinsically separate from skeletal muscle size (Chilibeck
et al., 1998; Clark et al., 2008). Moreover, skeletal muscle tissue
has varied physiologic roles that impart wide ranging effects on
multiple body systems. Therefore, careful consideration should
be given to the operational definition of “muscle quality” since
its interpretation is affected by the specific physiologic function
of interest and the methodology used to characterize tissue or
measure performance.
Muscle quality has been described in myriad ways by
clinicians and investigators. Hazzard’s Geriatric Medicine and
Gerontology aptly conveys the broad concept of muscle
quality with a description that includes glucose metabolism,
oxidative damage, protein metabolism, intramuscular adipose
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tissue, capillary density, structural composition, contractility
and fatigability (Hazzard and Halter, 2009). Furthermore,
those that conduct sarcopenia-related studies have frequently
used relative force production (expressed as a ratio of peak
force and a measure of body size, regional LBM, or cross-
sectional area) as a preferred approach to characterizing muscle
quality (Cawthon et al., 2009; Scott et al., 2010; Kennis
et al., 2014). The term, muscle quality—despite its ambiguity—
has served the useful purpose of allowing investigators to
explore facets of skeletal muscle function deficit beyond the
construct of the age-related decline of LBM. Uniformity
and clarity, however, are needed regarding the definition of
muscle quality and the measurement methodology. The general
definition of quality incorporates an object’s “essential character”
and its “distinguishing attributes,” and may also include a
comparative “degree of excellence” (Merriam-Webster, 2004).
Thus, the inherent meaning of muscle quality is inextricably
linked to the primary functions of skeletal muscle, and
this meaning may be further expanded to consider normal
physiology vs. pathophysiology. The term, skeletal muscle
function deficit (SMFD), was coined by Correa-de-Araujo and
Hadley (2014) to encompass the evolving concepts of sarcopenia
and other aging-related muscle dysfunction that contribute to
clinically meaningful mobility impairments (Correa-de-Araujo
and Hadley, 2014). In considering other conditions that are
clinically manifested as impaired physiologic functions and have
multiple contributory factors (e.g., congestive heart failure and
chronic obstructive pulmonary disease), this type of diagnostic
evolution may accommodate both therapeutic progress at a stage
when mechanistic information has been limited, and further
progress as mechanistic understanding continues to increase.
Therefore, in building a framework for muscle quality, it is
critical to note the complexity of skeletal muscle tissue and
its physiologic roles that include not only movement via force
production, but also metabolism through its maintenance of
glucose/insulin homeostasis and amino acid storage (Miljkovic
and Zmuda, 2010), thermoregulation, and autocrine, paracrine,
and endocrine signaling via myokine production (Pedersen,
2011; Ahima and Park, 2015; Colaianni and Grano, 2015).
Considering this expansive view of muscle quality is essential to
improving our understanding of SMFD. Muscle quality would
then be ultimately determined by the degree that muscle tissue
fulfills its roles. This includes function while at rest and in
response to increased demands, within the limits of normal
physiological capacity and reserve.
A proposed conceptual model for muscle quality may
be built upon on the primary physiologic functions of
muscle tissue and categorized in domains: force production,
metabolism, thermoregulation, signaling/myokine production.
Although muscle force production is perhaps the most
prominent characteristic of muscle tissue, this observation
does not mitigate the relative importance of skeletal muscle
for glucose/insulin homeostasis and other biological functions.
While the term “muscle quality” resists easy characterization, it
shares many of the well-documented limitations of terminology
used to describe the broad construct of muscle performance
(Kluger et al., 2013). Many endpoint variables ranging from
specific force to the proportional measures of intermuscular
fat have been used to quantify muscle quality. Selecting
ideal endpoint measures to better understand the muscle
quality domains are dependent on the following factors: (1)
established measurement analytics (e.g., validity, reliability, and
responsiveness), (2) a meaningful association with a major
domain of muscle quality, and (3) clear utility for research
and/or clinical purposes. This conceptual orientation would
be appropriate for both mechanistic and clinical approaches
to characterize muscle quality and pursue specific lines of
hypothesis-driven research. While no ideal singular endpoint
measure is suitable to characterize muscle quality, consensus
could be attained to recommend standardized approaches to
endpoint measures within each of the major domains of muscle
quality. These recommended endpoints should be categorized
based on their suitability for either research settings or clinical
environments. Subsequent research will determine the relative
importance of selected endpoint measures of muscle quality.
Investigators will utilize outcomes that are the most strongly
associated with mechanisms that govern muscle performance or
predict mobility status and mortality in older adults. This view of
muscle quality further untethers investigators from a strict LBM-
driven assessment approach to sarcopenia research, andmay help
to end the conflation between “measurement methods” and the
targeted “domain” of muscle quality. This perspective is reflected
in the ongoing research concerning the local and systemic effects
of myosteatosis, and emerging methods to quantify changes in
muscle tissue composition and function.
EFFECTS OF MYOSTEATOSIS ON
METABOLIC STATUS
Muscle architecture, composition, metabolism, fat infiltration,
fibrosis, and neural activation are among the multiple factors
potentially influencing muscle quality (McGregor et al., 2014).
Over the past decade, myosteatosis, the ectopic fat infiltration
in skeletal muscle, has emerged as an important factor
underpinning muscle quality and also as a possible predictor of
muscle function and metabolic status (Miljkovic and Zmuda,
2010). Myosteatosis is a unique ectopic fat depot with broad
clinical sequelae including poor metabolic and musculoskeletal
health, accelerated aging and impaired longevity (Goodpaster
et al., 2000, 2001, 2003; Visser et al., 2005; Miljkovic and Zmuda,
2010; Wijsman et al., 2012; Miljkovic et al., 2013b). Essentially,
two modalities of fat depots are identified within skeletal muscle
with varying functions (Vettor et al., 2009; Miljkovic and Zmuda,
2010): (1) Intermuscular fat defined as the visible extracellular
adipose tissues located beneath the muscle and between and
within muscle groups (Manini et al., 2007); (2) Fat infiltration
within myocytes (known as intramuscular fat or intramyocellular
lipids), which represents the microscopic lipid droplets utilized
as energy within the muscle. Ectopic fat deposition in skeletal
muscles progressively increases with aging, and seems to act
synergistically with sarcopenia (Narici and Maffulli, 2010; Budui
et al., 2015). Myosteatosis is also a finding common to muscular
dystrophies and aging muscles.
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Local and Systemic Effects of
Myosteatosis
Myosteatosis and Muscle and Mobility Function
Myosteatosis is not an inert fat depot that simply fills the
space left by lean mass loss. Excessive levels of myosteatosis
may negatively affect skeletal muscle tissue. For example, in
young healthy individuals subjected to 30 days of leg disuse by
suspension, myosteatosis increased 15–20% and exceeded the
loss of lean calf and thighmass (Manini et al., 2007). Myosteatosis
may affect the muscle performance and physical mobility
(Figure 1). High levels of myosteatosis are also associated with
decreased activation of the quadriceps muscles in older adults
(Yoshida et al., 2012a). Increased mobility loss, reflected by
decreased 6-min walk distance (Marcus et al., 2012), decreased
gait speed (Visser et al., 2002), decreased physical performance,
difficulty with repeated chair stands (Visser et al., 2002), and
slower stair descent and timed get-up and go tests (Marcus et al.,
2012), is also the result of the effects of myosteatosis on muscle
metabolism and function. Myosteatosis may also lead to the
transition of muscle fibers from type II to type I (Mastrocola et al.,
2015). This transition would result in muscles with impaired
contractile capacity and decreased power (Reid and Fielding,
2012). Future studies are needed to elucidate the mechanisms
(i.e., metabolic or mechanical changes) behind the increased
myosteatosis and decreased muscle and mobility function.
These studies should determine if minimizing myosteatosis
is accompanied by improved muscle and mobility function
(Goodpaster et al., 2001; Visser et al., 2005; Manini et al.,
2007; Marcus et al., 2012; Tuttle et al., 2012; Yoshida et al.,
2012a).
Myosteatosis and Metabolism
There is a growing body of research on myosteatosis and its
systemic effects related to metabolic disorders. It is known
that independent of total body adiposity, measured either by
body mass index (BMI) or dual energy X-ray absorptiometry
(DXA) whole body fat, myosteatosis has been associated
with insulin resistance and an increased risk of developing
type-2 diabetes (Goodpaster et al., 2003; Miljkovic et al.,
2013a, 2016), hypertension (Ding et al., 2004; Miljkovic
et al., 2013a; Therkelsen et al., 2013), and dyslipidemia
(Miljkovic et al., 2013b), usually detectable much earlier than
the onset of metabolic disorders (Savage et al., 2007). The
link between myosteatosis and metabolic disorders could be
theoretically attributed to the relationship of myosteatosis and
overall adiposity. With increasing adiposity, there is also an
increase of the fat infiltration in the muscle (Gallagher et al.,
2005). However, the association between myosteatosis and
metabolic risk factors remains strong even after accounting
for BMI, suggesting that these metabolic impairments are not
simply due to obesity alone. The findings on the association
between myosteatosis and metabolic disease independent of
visceral fat have been inconclusive; it is unclear as of yet
whether myosteatosis is associated with metabolic disorders
when visceral and other ectopic fat depots are taken into
account.
FIGURE 1 | Potential mechanisms underlying the effects of myosteatosis. Increased myosteatosis may lead to metabolic and mechanical changes in the
muscle through a variety of mechanisms. Changes in muscle cell metabolism can lead to increased insulin resistance and inflammation, aiding in the development of
diabetes, and cardiovascular diseases. Alterations in muscle architecture can also lead to muscular dysfunction and functional decline. Both processes may be
increased through activation of proteolytic systems, which may also result from increased myosteatosis.
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The metabolic consequences of myosteatosis depend on: (1)
age, (2) race/ethnicity, (3) aerobic fitness levels, (4) sensitivity
to insulin, (5) amount of physical activity, and (6) anatomical
region. Myosteatosis has been found to increase with age, and the
deposition of ectopic fat accelerates over time (Delmonico et al.,
2009). In addition, compared with Caucasians, African ancestry
individuals and South Asians may have more myosteatosis
independent of differences in general adiposity (Miljkovic et al.,
2009). Interestingly, marked increases in myosteatosis can have
both adaptive and maladaptive effects on muscle function
and metabolism. The “Athlete’s paradox” is a phenomenon
observed in endurance-trained athletes, who possess higher
intramyocellular lipid content, coupled to high oxidative capacity
and enhanced insulin sensitivity (Dubé et al., 2008). Athlete’s
paradox clearly demonstrates that intramyocellular fat does not
always have deleterious effects and that there may be other
“bad” lipids in muscle. Finally, due to a different function and
morphology of skeletal muscles, increased fat infiltration in
certain muscles may be found in normal physiologic conditions
and may not have a harmful effect on metabolism. For example,
under normal physiologic conditions, myosteatosis is lower in
the tibialis muscle but higher in the soleus (Goodpaster et al.,
2004; Lawrence et al., 2010). It is currently unknown whether
myosteatosis acts merely as a marker of metabolic dysfunction
or whether it may have an intermediary or modifying role in
insulin resistance. More mechanistic and epidemiologic studies
are needed to elucidate these questions (Gallagher et al., 2005;
Yim et al., 2007; Miljkovic-Gacic et al., 2008; Boettcher et al.,
2009; Ryan et al., 2011).
Potential Determinants of Myosteatosis
Despite the growing clinical relevance of myosteatosis, the
biological mechanisms underlying increases in myosteatosis with
aging in humans remain considerably unknown. Current theories
are largely based on animal models or controlled experimental
studies in small samples of humans. Some propose that increased
myosteatosis may result from increased fatty acid transport,
uptake and storage, and reduced fatty acid oxidation (Kim et al.,
2000; Kelley and Goodpaster, 2001). Other experiments suggest
that macrophage infiltration inhibits adipocyte differentiation,
and leads to adipocyte hypertrophy, altered cytokines secretion,
and increased fat accumulation in muscle and other non-adipose
tissues (Hegarty et al., 2002). It is also thought that an excess
lipid availability and high-fat diet may reduce the mitochondrial
respiratory chain components in muscle. Impaired skeletal
muscle mitochondrial function, which directs fatty acids toward
storage as opposed to oxidation, may also contribute to aging-
related increases in skeletal muscle fat accumulation (Roden,
2005; Mathieu et al., 2010). Another potential mechanism for
these alterations involves the possible age-related change in
activation, proliferation, and differentiation of quiescent skeletal
muscle precursor “stem” cells (i.e., satellite cells) into adipocytes
in response to a range of stimuli that occurs with aging.
Inadequate storage of excess fat in subcutaneous fat depots
during excess lipid availability has also been identified as a
potential cause of the increased myosteatosis. The subcutaneous
fat depot may act as a metabolic “sink,” which can accommodate
excess lipids and thus prevent the flow of lipid to vital organs. A
better understanding and identification of the biological factors
that regulate myosteatosis with aging, including the evidence of
senescent cells and cultured cells developing into preadipocytes
and fat cells (Tchkonia et al., 2010), is imperative for developing
new strategies for promoting metabolic and musculoskeletal
health. Such biomarkers could become targets for novel therapies
to preserve a more functionally and metabolically “healthy”
skeletal muscle with aging (Mathieu et al., 2010; Tchernof and
Després, 2013; Smith, 2015).
Potential Mechanisms Underlying the
Effects of Myosteatosis
Though the specific mechanisms underlying the detrimental
effects of myosteatosis on local and systemic muscle metabolism
remain unknown, several hypotheses have been proposed that
support this relationship (Albu et al., 2005; Gallagher et al.,
2005; Durheim et al., 2008; Lee et al., 2009; Vettor et al., 2009;
Kovalik et al., 2011; Trayhurn et al., 2011). It is theorized that the
close proximity of fat to the muscle fiber may impair the local
muscle environment through elevated levels of local or systemic
pro-inflammatory cytokines (Vettor et al., 2009; Zoico et al.,
2010) or throughout the impaired myokine secretion (Brandt
and Pedersen, 2010). Increased myosteatosis may also impair
nutritive blood flow to muscle and thus impair insulin action and
insulin diffusion capacity (Lee et al., 2009). Additionally, recent
findings indicate that an increased number of inter-muscular
adipocytes have a direct local impact on skeletal myocyte
metabolism, causing enhanced myotube mRNA expression of
genes involved in oxidative metabolism (Lowell and Shulman,
2005; Kovalik et al., 2011). This study suggested that even a
relatively small amount of intermuscular fat may be sufficient
to drive myotubes into lipid oxidation and affect skeletal muscle
metabolism. However, these effects depended on the metabolic
state of the system. It is also hypothesized that the increasing
rate of lipolysis within skeletal muscle results in an elevated
concentration of glucose within the skeletal muscle (Yim et al.,
2007; Turcotte and Fisher, 2008). From animal models, it has
been shown that insulin resistance observed in old high-fat diet
fed rats is independently related to myosteatosis, and that it
can be induced by high ceramide synthesis (Tardif et al., 2014),
stimulated by adipocyte-derived cytokines (including tumor
necrosis factor-α; Summers and Nelson, 2005; Tardif et al., 2014)
and consequent decrease in the ability to upregulate muscle
insulin pathways.
In addition to the possible effects of myosteatosis on
muscle and mobility function through changes in local muscle
metabolism, myosteatosis may also be harmful to muscle and
mobility function due tomechanical changes inmuscle that occur
in the presence of myosteatosis, leading to changes in muscle
fiber orientation (Yoshida et al., 2012a). Along with the loss of
elasticity in rotator cuff muscles, it has been hypothesized that
excess myosteatosis leads to an alteration in contractile fiber
pennation angle, hence resulting in an unfavorable mechanical
angle and a concomitant reduction in force production (Meyer
et al., 2004; Gerber et al., 2007). To our best knowledge, no
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studies have examined the effect of myosteatosis on elasticity
or of pennation angle in locomotor muscles. Finally, pro-
inflammatory cytokines (Vettor et al., 2009) secreted by adipose
tissue in the skeletal muscle microenvironment may lead to
proteolysis and muscle catabolism (Ebisui et al., 1995; Hegarty
et al., 2002; Zoico et al., 2010). Figure 1 summarizes the potential
mechanisms underlying the effects of myosteatosis.
Imaging Measures of Myosteatosis
Image-based methods of assessing myosteatosis are applied
primarily in research settings, and are not yet in routine clinical
use. Based on these facts, there is a need to establish an objective,
valid, reliable, and standardized measure of quality derived from
the composition of the skeletal muscle. MRI of a cross section
of the thigh of young and old males and females matched
for weight and height demonstrate that fat infiltration is not
an issue of being overweight, but a sign of important changes
with aging (Petrella et al., 2007). MRI is an excellent non-
invasive technique for measuring myosteatosis, providing high-
quality images. However, the cost is high, and traditional MRI
does not typically allow quantification of the fat content of the
muscle. Recent MRI work is aiming to assess myosteatosis using
a method for fat/water separation. Chemical shift-based MRI
has demonstrated an advantage over single voxel spectroscopy
in readily determining tissue heterogeneity within muscle fat
fractions in both normal and dystrophic muscles (Triplett et al.,
2014).
Other imaging techniques also facilitate the non-invasive
evaluation of myosteatosis. Computed tomography (CT) has
thus far probably been the most utilized as a research tool
to investigate myosteatosis. It is basically assessed indirectly
using muscle attenuation calculated CT imaging scan, leading
to close correlation with direct measurements of muscle lipid
content (Machann et al., 2003; Larson-Meyer et al., 2006). Muscle
radiation attenuation is a radiological characteristic that can be
measured (Goodpaster et al., 2000; Goodpaster, 2002). Any given
skeletal muscle displays radiation attenuation between −190
and +150 Hounsfield units (HU), with a prominent peak near
+50 HU. When muscle cross-sectional area and attenuation are
reported, the most common practice is to use pre-established HU
ranges to define intermuscular fat (usually−190 to−30 HU) and
muscle tissue (usually −29 HU to 150 HU; Aubrey et al., 2014).
Although radiation exposure is a disadvantage, compared to CT
scans of the trunk, the effective dose to the extremities is typically
very small. CT also cannot isolate individual muscle groups. New
dual or multispectral CT imaging methods may offer improved
tissue discrimination in future studies.
Standard MRI, CT, and DXA imaging are techniques
frequently utilized in large clinical trials, but one of their
major limitations is that they cannot directly measure the lipid
content or detect the location of fat storage within myocytes
(intramyocellular fat) or lipid droplets surrounding myocytes
(extramyocellular fat, which are present in very small quantities;
Goodpaster, 2002; Machann et al., 2003; Karampatos et al., 2016).
Due to its biochemical specificity, the use of magnetic resonance
spectroscopy (MRS) is a valuable approach in measuring
intramyocellular lipids. However, one of its limitations is high
cost. In addition, while MRS can be done on many of the newer
MRI machines, it requires more advanced work to set up and
is unlikely to be available at most clinical facilities. It should
also be noted that ultrasonography equipment is an emerging
option for muscle tissue imaging. Ultrasound is commonly
available at clinical centers, portable, and much cheaper than
other imaging methods. However, like other common imaging
methods, ultrasound has limitations in distinguishing between
intramyocellular and extramyocellular fat.
While we are primarily relying on imaging techniques at this
time, there is a pressing need for developing a rapid, easy to
use, portable and cost-effectivemethod for assessingmyosteatosis
in clinical settings. Fat infiltration in skeletal muscles increases
with aging and influences muscle’s metabolic and contractile
function. A growing area of research on myosteatosis would
benefit from a standardized approach to quantify myosteatosis
across research studies. In addition, it is important to consider
the population studied and the questions posed. More basic
science and epidemiologic studies will be needed to determine the
mechanisms responsible for increasedmyosteatosis with aging, as
well as mechanisms underlying the effects of myosteatosis.
DETERMINANTS OF MUSCLE QUALITY:
FUNCTIONAL APPROACHES TO MUSCLE
QUALITY ESTIMATES
While elements of muscle quality can be described using
measures of muscle composition or myosteatosis, the impact of
these muscle characteristics may be most relevant to mobility
outcomes and the need for intervention in older adults. Muscle
quality may be considered as a broad concept used to elucidate
and describe muscle function, and it is largely influenced by
the intricate intramuscular ultrastructure and morphology of
contractile tissue. Structure-function relationships also affect
muscle quality and can be described, in part, according to the
“size principle” (Henneman, 1985). This principle holds that
the functional potential of a skeletal muscle depends on the
motor unit array and its sequential recruitment according to
force demand. Functionally, the size principle of motor unit
recruitment affects the tissue’s capacity to perform its various
functions such as generating force and aiding metabolism. Each
of these functional roles may be impacted by changes in muscle
composition and structure. Qualitative features of skeletal muscle
tissue, such as composition, architecture, and morphology of the
contractile apparatus translate into a variety of structural and
functional indices of muscle quality (Fragala et al., 2015b).
Functional Consequences of Myosteatosis
The functional impact of intermuscular fat has been
demonstrated by several studies in which higher intermuscular
fat was associated with poorer muscle function and strength
(Goodpaster et al., 2001; Visser et al., 2002; Manini et al., 2007;
Hilton et al., 2008; Delmonico et al., 2009). This appears to
be related to a functional contractile hindrance within the
muscle (Cesari et al., 2006; Lauretani et al., 2006; Schrager et al.,
2007). A closer examination of muscle structure reveals how
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intramuscular fat may impede muscle function. With aging, the
motor unit array may become compressed due to a decrease
in both size and number of muscle fibers, particularly in type
II fibers (Tomonaga, 1977; Larsson and Karlsson, 1978; Lexell
et al., 1988). In fact, autopsy studies (Lexell et al., 1983) reveal
25% fewer muscle fibers in the medial vastus lateralis of older
adults (72 ± 1 years) in comparison to younger individuals
(30 ± 6 years). Moreover, aged skeletal muscle shows a variety
of changes within the extracellular matrix, including collagen
accumulation and altered elasticity (Kragstrup et al., 2011).
The compressed motor unit array resulting from myosteatosis
and non-contractile tissue accumulation may impede muscle
activation and force production in older adults (Yoshida et al.,
2012b).
In addition to muscle fiber size and number, biopsy studies
also show changes in other qualitative characteristics of aged
skeletal muscle such as changing fiber type distribution, in which
the percentage and area of type II fibers in the vastus lateralis are
reduced (Larsson and Karlsson, 1978). Accompanying changes
in fiber type distribution within skeletal muscle are alterations
in metabolism characterized by decreases in oxidative enzyme
activity and muscle capillarization (Rogers and Evans, 1993).
Examination of muscle biopsies of less functional or “clinically
weak” muscle compared to “normal aged muscle” reveals
qualitative differences in fiber packing, shape, intramuscular
lipid distribution, and connective tissue (Fragala et al., 2014).
Yet, despite the detailed characteristics of the individual muscle
fibers (or cells) provided in muscle biopsy analysis, routine
muscle biopsy procedures using the Bergstrom needle biopsy
technique (Bergstrom, 1975) are invasive procedures not suitable
for routine muscle quality assessment. Recent developments in
fine needle biopsy techniques show promise for muscle histology
assessment (Townsend et al., 2016) with far less pain and
discomfort (Hayot et al., 2005).
Muscle Architecture
Cross-sectional muscle assessment yields important information
about muscle function, as both individual muscle fiber diameter
and cross sectional diameter of whole muscle are associated with
muscle function as strength (Verdijk et al., 2010). Yet whole
muscle contracts with the longitudinal shortening of muscle
fibers by the sliding on the actin andmyosin within the sarcomere
units. Thus, assessment of both longitudinal and cross-sectional
features of muscle architecture each provide important insights
into muscle functioning. Ultrasonography enables the valid
and reliable assessment of a variety of muscle architectural
characteristics, such as anatomical cross-sectional area, muscle
thickness, pennation angle, fascicle length, and echogenicity
measured using grayscale analyses (i.e., a measure related to
muscle density and myosteatosis; Cadore et al., 2012; Scott et al.,
2012; Cartwright et al., 2013). Moreover, some evidence exists
to show that local muscle hypertrophy may be detected on
ultrasound before changes in DXA are apparent (Scanlon et al.,
2014).
The muscle quality domain of force production is related
to the architectural characteristics of skeletal muscle (Gans and
de Vree, 1987; Gans and Gaunt, 1991; Fukunaga et al., 1997;
Lieber and Friden, 2000), including muscle fiber length and
arrangement in relation to the direction of force produced by
the whole muscle (Gans and de Vree, 1987). Consequently,
both cross sectional and longitudinal orientation measures of
skeletal muscle have value in the evaluation of the size-strength
relationship and the existence of age-related differences inmuscle
strength per size (Akagi et al., 2009). Longitudinal assessment by
electron microscopic analysis of human skeletal muscle reveal
sarcomeric changes in myofibrillar disorder, Z-line streaming,
and dilatation in aged skeletal muscle (Scelsi et al., 1980). In
consideration of such factors, architectural characteristics can
be combined into a composite measure, often referred to as
physiological cross-sectional area (PSCA)—a measure that is
related to both leg extension strength and change in leg extension
strength in older adults (Scanlon et al., 2014).
Measures of Muscle Strength and Function
Absolute and Relative Muscle Strength
Measures of muscle composition, size, and architecture do not
consider the neural input into the muscle fibers that dictate
contraction potential and force production. Neural input is a
critical component in muscle functioning, as cross-education
models have shown increases in strength in an untrained
limb through resistance training, without detectable changes in
muscle size or the acute hormonal response (Beyer et al., 2016).
According to the “Size Principle” of motor unit recruitment,
functional measures of force output or strength reflect a
muscle’s ability to recruit fibers associated with motor unit
arrays. Muscle weakness is collectively attributed to alterations
in muscle composition, muscle contractile quality, and neural
activation (Clark and Manini, 2010). As such, strength measures
represent an important measure of muscle performance. This
concept serves the basis of the FNIH model of sarcopenia,
in which thresholds to define clinical weakness (i.e., grip
strength <26 kg for men and <16 kg for women) have been
associated with functional mobility consequences and incident
mobility impairment (Alley et al., 2014; McLean et al., 2014;
Studenski et al., 2014). In comparing grip to leg strength, both
measures have been deemed suitable for screening for muscle
weakness in older adults (Fragala et al., 2016). Moreover, strength
measures show the ability to change in response to a variety of
interventions for sarcopenia and frailty in older women with
clinically meaningful muscle weakness, regardless of the presence
of low lean mass (Fragala et al., 2015a). Recent work has further
demonstrated the relation between the age-related decline in
grip strength and forearm muscle quality (Abe et al., 2016).
Muscle strength and size are commonly incorporated into a
single measure of “muscle quality,” often referred to as relative
strength. While little consensus exists on measures of strength
and size that go into the equation, the common feature of the
metric is the expression of muscle force production relative to
muscle or body size. Like measures of muscle strength, measures
of relative strength increase with resistance training intervention
(Scanlon et al., 2014). Strength per unit of muscle tissue may
provide a better indication of age-related differences in muscle
quality prior to changes in lean tissue mass (Francis et al., 2016).
Regardless, some evidence suggests that the relationship between
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relative strength and functional outcomes such as gait speed
and chair rise may be restricted to older men, whereas BMI or
adiposity appears to be the predictive factor in older women
(Fragala et al., 2012; Straight et al., 2015).
Muscle Quality Index
Despite the value of relative strength measures, the required
apparatus for some assessments such as PSCA continue to
be difficult to incorporate into routine clinical assessment.
As such, a variety of simple functional assessments have
been explored for muscle function and elements of muscle
quality such as grip strength, chair rise performance, and
the timed get-up and go test, which have been shown to be
predictive of subsequent mobility limitations (Guralnik et al.,
1995). Importantly, consideration of body size enhances the
interpretation of such tests. One novel functional metric that
includes the features of a clinical test and simple body size
measures has been referred to as the Muscle Quality Index (Takai
et al., 2009), which provides a clinical measure of muscle power
(Barbat-Artigas et al., 2012). This test is based on time to perform
the simple chair rise. It also factors in body size and leg length into
the equation. The Muscle Quality Index estimates muscle power
from body anthropometrics and timed chair rises (Figure 2). It
elaborates on the typical chair rise test by accounting for the
anthropometric measures of body mass and leg length, which
have been shown to alter the relationship between chair rise
performance and leg strength (Takai et al., 2009). The validity
and reliability of the Muscle Quality Index have been reported by
Takai et al. (2009). In comparison to other functional measures
(e.g., gait speed, grip strength, the get-up, and go test, etc.), the
Muscle Quality Index has higher reliability and exhibits greater
responsiveness following a resistance exercise regimen in older
adults (Fragala et al., 2014).
The force production capacity of skeletal muscle may be
the most prominent domain relating muscle quality to mobility
outcomes. Skeletal muscle architecture characteristics may be
significantly associated with force production capacity. In
addition, simple functional tests such as theMuscle Quality Index
may allow for muscle quality assessments in a variety of settings.
Regardless of the myriad approaches, the need remains for
consensus on the functional assessments of muscle quality that
represent the contractile function of muscle tissue, are feasible in
clinical environments, and are responsive to changes following
intervention.
ALTERNATIVE CLINICAL IMAGING
MEASURES OF MUSCLE QUALITY
Tissue composition and morphology are elements of muscle
quality that affect all domains of muscle function. Imaging
FIGURE 2 | A proposed performance-based index of muscle power. (A–D) The Muscle Quality Index (MQI) is a performance-based functional assessment
involving ten repetitions of the sit-to-stand maneuver performed as rapidly as possible. The test requires the use of a scale to record body mass (A), a tape measure
to obtain leg length (B), along with a stopwatch and chair and for the timed functional task (C,D). The MQI score is calculated using the following equation: ((leg length
× 0.4) × body mass × gravity × 10)/sit-to-stand time.
Frontiers in Physiology | www.frontiersin.org 8 February 2017 | Volume 8 | Article 87
Correa-de-Araujo et al. Standardized Assessment of Muscle Quality
modalities serve as a non-invasive approach to assess both
tissue composition and body composition. Quantitative
musculoskeletal diagnostic ultrasound has been proposed as
a clinically viable means of characterizing muscle structure.
Greater adoption of this sonographic method will occur if it
helps the practitioner discriminate between older adults with
and without sarcopenia and identify those at risk for impaired
muscle performance.
Muscle Tissue Composition as a Window
into Muscle Quality
Muscle mass is strongly coupled with muscle strength during
the course of maturation through young adulthood. However,
it has been observed that the relationship between muscle mass
and strength decreases in magnitude as one ages, and that the
age-related loss of muscle strength may occur more rapidly than
the loss of LBM (Landers et al., 2001; Ferrucci et al., 2011). The
measurement of muscle strength remains a vital outcome within
the realm of geriatric assessment. Nevertheless, the isolated
detection of low muscle strength cannot be used for staging
or diagnosis, since there are varied causes of myogenic and
neurogenic weakness that require additional medical follow up
for the differential evaluation. Moreover, there is some evidence
that diminished muscle tissue composition may precede losses in
muscle mass as a contributing factor to the age-related decline in
strength (Visser et al., 2005; Goodpaster et al., 2006; Watanabe
et al., 2013; Ismail et al., 2015).
There are varied approaches to assessing the microscopic
and gross morphological features of skeletal muscle tissue
that may affect muscle quality. Muscle architecture consists of
the macroscopic morphology of skeletal muscle based on the
muscle shape and its fiber arrangement relative to the axis of
force generation (Anneriet et al., 2007; Lieber, 2010). Whereas,
muscle ultrastructure (also called, muscle microstructure) is the
microscopic characterization of muscle tissue and its specialized
cellular components and organization. This approach to myology
dates back to Van Leeuwenhoek’s light microscope studies in
1712 and was more fully elucidated in the seminal publication
of the “Skeletal Muscle” Section of the Handbook of Physiology
by the American Physiological Society in 1983 (Peachey et al.,
1983). The study of muscle ultrastructure traditionally includes
cytology, histology, surface morphology, and other anatomical
approaches (Lieber, 2010; Eisenberg, 2011).
Regarding body composition assessment, multiple models
exist which range from the molecular and cellular level to the
tissue/organ and whole body level. However, all estimates of body
composition are limited by a lack of true direct measurement
(Heymsfield et al., 2015). Composition estimates are largely based
on biochemical or tissue density qualities, with imaging methods
typically incorporating a tissue/organ level of measurement (i.e.,
skeletal muscle tissue, adipose tissue, osseous tissue, visceral
organs, and other tissues) or a whole-body level of measurement
(i.e., head, trunk, and appendages) based on fat mass, fat-free
mass, and bone mass. The use of imaging modalities as a non-
invasive means of body and tissue composition assessment has
a long history of usage in medical facilities. Although DXA,
MRI, and CT are deemed acceptable tools for this purpose,
significant barriers limit their incorporation into the sarcopenia
staging process. DXA is perhaps the most widely accepted
imaging modality for the estimate for LBM (expressed as total
LBM or aLM/ht2) for sarcopenia staging, but it does not yield
useful information concerning muscle quality based on adverse
changes in muscle tissue composition. Both MRI and CT do
provide estimates of muscle tissue composition, but CT is
limited by its relative high ionizing radiation exposure, and
MRI use is often beset by concerns related to access and cost.
Standard segmental bioimpedance analysis (BIA) or refinements
such as multi-frequency electrical impedance analysis could
prove to be a non-imaging modality capable of characterizing
elements of muscle quality. The phase angle derived from BIA
has been associated with diminished strength in older adults
and serial measures may partially reflect age-related changes
in muscle tissue (Heymsfield et al., 2015). Both BIA and
diagnostic ultrasound have comparative advantages, with the
former having a low cost suitable for field use, and the latter
having the additional ability to capture morphological features of
skeletal muscle. Diagnostic ultrasound has been proposed as an
alternative imaging modality for the use of sarcopenia screening
and staging due to its portability, relatively low cost, and potential
ability to provide proxy estimates of muscle tissue composition
(Reimers et al., 1993; Sipilä and Suominen, 1993; Harris-Love
et al., 2014).
Quantitative Sonography: Considering the
Role of Muscle Tissue Composition within
the Sarcopenia Screening Paradigm
Recent results from Cawthon and associates (Cawthon et al.,
2015) involving the Osteoporotic Fractures in Men (MrOS)
cohort were consistent with previously reported findings
regarding the association of LBM with reported falls, limitations
in mobility, and mortality. However, these investigators noted
that staging individuals for sarcopenia using the major LBM
cut off values only served to decrease the estimated risk of
an adverse outcome in people within the cohort that had an
event. The predictive value of LBM concerning morbidity and
mortality in these community-dwelling older men did not exceed
the predictive value of age alone. In contrast, findings from
other studies involving large cohorts of community-dwelling
older adults have indicated that muscle strength and muscle
quality (based on ratios of strength and regional LBM, or
tissue density algorithms involving Hounsfield units derived
from CT scanning), but not muscle size or LBM, portend
increased risk of hospitalization and incident disability (Cawthon
et al., 2009; Hairi et al., 2010). Estimates of muscle quality
based on CT scanning estimates of tissue density have been
shown to be significantly associated with ultrasound echogenicity
in samples of older women (Sipilä and Suominen, 1993).
Moreover, preliminary evidence supports the observation that
high echogenicity values obtained from anterior quadriceps
ultrasound scans are associated with decrements in muscle force
independent of muscle mass levels in older adults (Watanabe
et al., 2013; Ismail et al., 2015).
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A recent study featuring an assessment of muscle mass via
DXA (e.g., aLM/ht2) and echogenicity as a proxy estimate of
muscle tissue composition revealed that estimates of muscle
quality via sonographic imaging were independently associated
with relative grip strength, whereas LBM was not (Ismail
et al., 2015). Upon accounting for both age and body fat
in the relationship between echogenicity (as measured using
grayscale histogram analysis; Harris-Love et al., 2016b) and
strength, both echogenicity and age were identified as significant
factors. However, echogenicity superseded age as a factor in the
preliminary model (rxyz = −0.52 vs. rxyz = −0.38). Indeed,
the study participants with higher levels of BMI and LBM
(LBM > 6.75 kg/m2) exhibited lower levels of relative grip
strength in comparison to those with lower levels of BMI
and LBM with Class I sarcopenia (LBM = 5.76–6.75 kg/m2;
Figure 3; Janssen et al., 2004a; Ismail et al., 2015). The collective
observations of investigators (Visser et al., 2005; Goodpaster
et al., 2006; Watanabe et al., 2013; Ismail et al., 2015) using
imaging modalities to assess skeletal muscle in older adults raise
the question, “Should an approach to muscle quality involving
tissue composition be introduced as an independent criterion
measure within the staging concept for pre-sarcopenia?” In
order to address this question, additional studies should validate
these reported observations in larger samples. These studies will
allow better understanding of whether estimates of muscle tissue
composition can be utilized as predictors of important clinical
outcomes in older adults.
FIGURE 3 | Relative peak grip force and muscle echogenicity
expressed in grayscale units. Grayscale measures derived from the
echogenicity of the rectus femoris have an inverse relationship with relative grip
strength (peak force scaled to body weight). The filled data markers (•)
represent study participants with Class I sarcopenia (5.76–6.75 kg/m2) based
on lean body mass estimates from DXA scanning, and the clear data markers
(◦) represent study participants with normal body mass (>6.75 kg/m2 ). BW,
body weight; scaled peak grip force, peak force in kg/body weight in kg; both
scaled peak force and grayscale values are unitless measures.
Measurement Considerations for Image
Acquisition in Quantitative Sonography
Key factors that affect quantitative sonography procedures
include the parameters associated with image acquisition,
the methods used during image processing and analysis,
the psychomotor skills of the examiner, and the wide array
of technological capabilities among commercially available
ultrasound machines. The selection of superficial muscle groups
to determine sonographic estimates of LBM and muscle
tissue composition confers some methodological advantages.
Superficial muscle groups are readily identified via gross
anatomical landmarks during the ultrasound examination. Also,
their use minimizes excessive attenuation of the sound waves due
to either large amounts of adipose tissue or the greater depth of
penetration required for deeper tissues (Harris-Love et al., 2014).
Typically, this approach to musculoskeletal imaging is aided by
the use of high frequency linear ultrasound transducers which
have a larger attenuation coefficient and may yield higher image
resolution of the targeted muscle groups. The use of anterior
axial and appendicular muscle groups have been proposed for
ease of access during the ultrasound examination for sarcopenia
staging (Ismail et al., 2015), but other approaches have been
effectively used to derive estimates of LBM (Abe et al., 1994).
Additional image acquisition parameters beyond the selected
scanning sites may also foster imaging consistency. Many muscle
groups with architectural features such a fusiform shape or
convergent/triangular structure near the tendinous insertionmay
benefit from scanning in the longitudinal view. Previous findings
from Zaidman and associates (Zaidman et al., 2008) indicated
that longitudinal view images may be more reliable than the
use of transverse view measurements when calculating calibrated
muscle backscatter values from elbow flexor scans (intraclass
correlation coefficients, ICCs, of 0.93–0.95 vs. 0.73–0.82). The
method used to identify the region of interest (ROI) within
the field of view may also impact estimates of muscle tissue
composition using echogenicity values. While both near field
and full muscle thickness ROI methods have been employed to
characterize aberrant changes in echogenicity, the heterogeneity
of age-related alterations in muscle tissue may merit the selection
of the full muscle thickness ROI during image analysis (Watanabe
et al., 2013; Harris-Love et al., 2016b).
Quantitative approaches to diagnostic musculoskeletal
ultrasound have been shown to be reliable for the measurement
of axial and appendicular muscle groups under controlled
conditions (O’Sullivan et al., 2007; Sions et al., 2014). Moreover,
investigators using quantitative sonography have exhibited good
reliability for morphometry and for measures of echogenicity
using grayscale histogram analysis and calibrated backscatter
calculations (Zaidman et al., 2012, 2014). Nevertheless, the
operator dependency of ultrasound measurements still exceeds
the influence of the examiner in standard DXA and CT
assessments of LBM. Although experience and training certainly
increases scanning and image acquisition consistency between
examiners, new modes of enhanced sonography have been
proposed to promote reliability across examiners during serial
imaging (Gilbertson and Anthony, 2013; Harris-Love et al.,
2016a). Using a standard ultrasound transducer augmented with
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axial force sensors, examiners with varied levels of experience
have demonstrated consistent material thickness measures
over a range of applied scanning forces (Harris-Love et al.,
2016a). Examiners with experience classifications of novice
(1 month), intermediate (1 year), and experienced (>10
years) attained a high degree of interrater reliability (ICC2,k
= 0.97, p < 0.001; coefficient of variation = 1.5–2.9%) upon
measuring a muscle mimetic ultrasound phantom utilizing up
to 10 N of applied force. This demonstrated ability to obtain
consistent image measurements at relatively high forces may
have clinical implications given that the observed applied forces
by sonographers may range from 5 to 14 N during abdominal
examinations (Gilbertson and Anthony, 2013).
The development of enhanced force control scanning
methods may continue to evolve and provide a viable alternative
for sonographic imaging in varied clinical settings under
realistic practice conditions. The technological advances of
sonography are developing at a rapid pace in comparison to
the contemporary innovations associated with DXA imaging.
The continual improvement in sonography technology, coupled
with the ongoing need to rectify image properties with tissue
properties across different ultrasound devices, will be the source
of opportunities and challenges in the quest for alternative
imaging assessments of muscle quality.
MEASURING AND CONTROLLING
ACQUISITION STATE IN QUANTITATIVE
MUSCLE SONOGRAPHY
Control systems have been engineered to address the major
sources of variability in sonography and enhance its applicability
to assess skeletal muscle quality. While this line of development
has produced promising preliminary results, as discussed
below, considerable efforts are still needed to better integrate
technologies into systems that can help clinicians evaluate muscle
quality. The measurement issues highlighted here, knowing and
controlling the pose of a probe on the body and the amount of
applied contact force—collectively referred to as the acquisition
state—are central issues to reducing variability in the use of
ultrasound to assess muscle quality.
Sonographer and Force Variations
Variations in ultrasound probe contact force lead to variations
in ultrasound images, making the images difficult to directly
and quantitatively compare with each other. The contact force
required to obtain an ultrasound image deforms the underlying
soft tissue. Conventionally, the probe-patient contact force
is controlled qualitatively by the human operator. A force-
measurement platform (Figure 4) has been developed, which
can simultaneously image andmeasure precise, operator-applied,
force. During an ultrasound exam, it was demonstrated that
contact forces exerted by the operator can vary, up to 50% over
30 s, resulting in images that are acquired at different levels of
tissue deformation (Gilbertson and Anthony, 2013). This force
measurement platform has been used to explore the impact of
preload the on elastic property estimates of Young’s modulus
in tissue and to characterize the average preload applied during
abdominal sonography (Dhyani et al., 2014); these values range
between 4.4 and 10 N. This preliminary analysis reveals trends
in applied force vs. years of experience and BMI of the patient.
Shown in Figure 5 are ultrasound images of the biceps from
a healthy subject, at four different applied forces. The muscle
thickness as measured from the bone to the subcutaneous fat-
muscle separation layer is highly dependent on force. Variable
compression impacts the quantities extracted from ultrasound
FIGURE 4 | Variation in shear wave elastography secondary to the applied scanning force. Significant variation in shear wave elastography estimates of
tissue Young’s modulus shown in the figure is a function of preload differences typical of clinical sonography. The varying preload conditions depicted are typical of
those seen across a range of operators in routine abdominal sonography and the resultant change in estimated tissue Young’s modulus. This variation is explained by
the observation that different bias compression levels pre-strain the tissue to different operating points along the tissue’s non-linear stress-strain response. Estimated
Young’s modulus increases from 21.1 to 64.1 kPa in the vastus medialis as applied force (preload) increases from 1 to 18 N.
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FIGURE 5 | Ultrasound images of the biceps from a healthy subject at four different forces. Variation in the muscle thickness (denoted by the height of the
yellow boxes), based on the measurement from the bone to the subcutaneous fat-muscle separation layer, is highly dependent on the examiner-generated force
during scanning.
image analysis. Physical parameters such as elasticity are biased
along the tissue’s non-linear stress strain curve. Image-based
parameters such as average grayscale level or and image texture
are directly altered under different levels of tissue compression.
Application of Force-Control to Duchenne
Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is characterized by
progressive disability leading to death and it remains one of
the most common and devastating neuromuscular disorders
of childhood (Bushby et al., 2010). It is caused by a genetic
mutation that generates a complex sequence of events in muscle
cells, which eventually undergo fibrosis and are replaced by
adipose and connective tissue. Although a variety of promising
new treatment strategies are in development, outcome measures
for clinical trials remain limited for the most part to a set
of functional measures, such as the 6-min walk test (Enright,
2003). While clearly useful, such measures are impacted by
unrelated factors, such as mood and effort, and have limited
repeatability. To address this and other limitations, magnetic
resonance imaging is now being investigated as a surrogate
measure (Willcocks et al., 2014). However, more easily applicable,
cost-effective, office-based surrogate measures that provide high
repeatability and sensitivity while still correlating strongly with
disease status would find wider use. The information embedded
in acquisition-state-controlled ultrasound images may provide
convenient, non-invasive, clinically meaningful markers of
muscle disease progression that surpass the functional measures
currently in use.
Clinically meaningful markers of muscle disease progression
in DMD are currently being developed. The potential for force-
correlated ultrasound imaging to enable automated classification
of muscle tissues structures in individuals with DMD has been
shown. Image-based quantities, such as variance maps (Koppaka
et al., 2014a), and image texture (Koppaka et al., 2014b), have
been used in classification schemes. Automated classification was
found to be improved when the biomarkers extracted (from
the quadriceps, biceps, forearm, tibialis anterior, and medial
gastrocnemius) were tagged with force information. Similar
methods may be used to promote ultrasound as a quantitative
non-invasive tool for not only classifying disease severity, but also
for tracking progression over time.
Force Variation in Elastography
Ultrasound elastography, whether strain elastography or shear
wave elastography (SWE), also suffers from operator-dependent
and acquisition state variation discussed above. Ultrasound
elastography limitations have been identified by scientists and
clinicians in the context of technique performance, clinical utility,
and work-flow. The most frequently acknowledged limitation
is repeatability and reproducibility. A few confounding factors
introduce bias and variation in stiffness measurement, including
operator dependence, concerning both strain elastography
and SWE, and cross-vendor system dependence of SWE
caused by different shear wave excitation mechanisms, tissue
mechanical models, and signal processing involved in stiffness
reconstruction. Before ultrasound elastography can be fully
adopted as a routinely used clinical tool for diagnosis and
therapy monitoring, these technical and clinical challenges must
be overcome by the entire industry.
Soft tissue is mechanically non-linear, meaning that
elastography measurement varies with the operator-applied
transducer force (i.e., preload). Preload-induced variation may
lead to inaccurate diagnosis and poses challenges to establishing
measurement standardization and clinical guidelines. Even with
SWE, which is considered more operator-independent than
strain elastography, stiffness measurement on the same tissue
can vary significantly. The results in Figure 4 show significant
variation in shear wave elastography estimates of tissue elasticity
as a function of preload differences typical of clinical sonography.
The varying preload conditions depicted, 1–18 N, are typical of
those seen across a range of operators in routine sonography
(Dhyani et al., 2014) and the resultant change in estimated tissue
Young’s modulus ranged from 21.1 to 64.1 kPa in the vastus
medialis. This variation is explained by the observation that
different bias compression levels pre-strain the tissue to different
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operating points along the tissue’s non-linear stress-strain
response.
Position and Orientation Variation: Skin as
a Body Location Encoding System
Knowing and controlling the position and orientation of an
ultrasound probe on the body is also a central issue to reducing
variability over serial examinations. Local skin appearance can be
used to help relocate a probe on the body. This is accomplished
by attaching a small camera to an ultrasound probe and capturing
high magnification images of the skin at the same time as the
ultrasound images.
Patterns of skin features are unique when viewing a sufficiently
large area of skin and include micro reliefs, follicles, moles,
and melanin variation (Figure 6). This uniqueness allows skin
to be used as a relative-motion or absolute-location encoding
system for the body. Based on this concept, a freehand ultrasound
platform has been developed which localizes an ultrasound probe
in 6-degree-of-freedom (DOF) with respect to the patient (and
not room coordinates) by tracking natural skin features (i.e.,
fiducial-free) with a small camera mounted to the ultrasound
probe (Sun and Anthony, 2012; Sun et al., 2013a,b). The system
comprises: (1) an optical camera kinematically coupled to an
ultrasound transducer, (2) software that extracts unique skin
features, and (3) software that localizes the transducer by tracking
the skin features (Sun and Anthony, 2012; Sun et al., 2013a,b,
2014).
The process involves simultaneously recording,
synchronously in time, ultrasound probe images inside the
body and camera images of the skin. Skin features are used to
track relative motion along the body. The same skin features
can be used to virtually identify and tag unique locations on
the body; this system permits placement of the ultrasound
transducer in the same body location and orientation by different
operators on serial examinations. In practice, multiple sources
of information, e.g., camera images and ultrasound images
and known regularities motion smoothness, are combined
for optimal probe pose estimation. In this way, a body-
contoured skin map is constructed and each ultrasound image is
accurately localized with respect to the map—a process termed
simultaneous localization and mapping (SLAM; Thrun and
Leonard, 2008).
This process results in a spatially accurate three-dimensional
(3D) ultrasound volume derived from a standard optically
tracked two-dimensional sonogram. Consequently, an
ultrasound probe may be approximately registered/relocated
at a known location and orientation with respect to patient
coordinates. The 3D volume could be used to generate multi-
planar images which should be nearly indistinguishable from
directly acquired ultrasound images (Sun et al., 2014). Sonograms
can be reformatted in any plane, allowing comparison of matched
images across serial examinations. The re-registration ability
should improve the ability to longitudinally monitor near-surface
or fixed location organs or tissue structures.
Along with improvement of the hardware technologies and
better integration into systems, significant research is needed
to further develop, refine, and validate analysis algorithms and
workflow software. These improvements would support the
effort to produce automated or augmented quantitative analyses
of ultrasound imagery applied to skeletal muscles. The rapid
technological advancements in ultrasound systems will continue
to have a meaningful impact on the assessment of muscle quality,
and perhaps expand the methods used for the screening and
staging of sarcopenia and other neuromuscular disorders.
SYMPOSIUM SUMMARY
The developing framework for assessing muscle quality allows
investigators to move away from a strict LBM-driven assessment
approach to sarcopenia research, and may help to end
the confusion between “measurement methods” and specific
“domains” of muscle quality. However, the need continues to
reach consensus on standardized approaches to assessing aspects
of muscle quality that influence the major functions of skeletal
FIGURE 6 | Sound transducer localization using unique skin features. A freehand ultrasound platform featuring an optical camera kinematically coupled to an
ultrasound transducer may be used with software that extracts unique skin features and provides transducer localization relative to the skin features. The ultrasound
transducer registration facilitates the acquisition of three-dimensional ultrasound volume estimates derived from a standard optically tracked two-dimensional
sonograms. This approach allows for scanned images to be generated and reformatted in any plane to allow for the comparison of matched images across serial
examinations.
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muscle and are likely part of SMFD. Some important messages to
consider as research efforts evolve include:
• The existent body of literature concerning myosteatosis
supports the premise that excessive ectopic fat depots in
muscle and intra-myocellular lipids impact both functional
decline and metabolic dysfunction in older adults.
• While current consensus-driven sarcopenia staging algorithms
relates to the loss of muscle mass, low strength, and
diminished functioning, the larger concept of age-related
muscle dysfunction may need to incorporate metabolic health
independent of mobility status or muscular strength.
• A measured approach to scaling factors regarding timed tests
of performance and force production may add value to the
clinical assessment of sarcopenia and themonitoring of patient
status following exercise-based interventions and other forms
of treatment.
• Quantitative diagnostic sonography and multi-frequency
electrical impedance analysis are clinically feasible approaches
to estimating tissue composition. These assessment tools may
aid the assessment of muscle quality in a variety of settings.
However, additional validation studies remain to be done in
order to move toward a wider adoption of these alternate
methods.
The current sarcopenia screening, staging, and classification
criteria should be open to periodic revision in light of the
continued evolution of performance-based testing and the
advances in imaging technology to assess muscle quality. Also,
features of skeletal muscle related to tissue characteristics may
ultimately serve to aid the sarcopenia diagnosis if such outcomes
exhibit utility in discriminating between patient groups and
predicting the incidence of metabolic disorders or disablement.
However, it is important to note that this symposium report
has limitations regarding the scope of the topics presented.
Other causative factors, such as reactive oxygen species (ROS),
negatively impactmuscle quality andmerit further consideration.
ROS plays an extremely important role in all muscle functions
and is closely related to muscle aging, contraction, fatigue,
dystrophy or waste, but this topic was beyond the goals of
symposium (Zuo et al., 2012, 2013, 2015; Min et al., 2015).
Finally, garnering consensus on the major domains of muscle
quality, and measurement methods suitable for a variety of
settings, remains a priority. Addressing the aforementioned
concerns may serve to advance skeletal muscle research in the
context of skeletal muscle function deficit and help identify
individuals who would benefit from interventions to improve
muscle quality.
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